From: Recent incidence trend of elderly patients with glioblastoma in the United States, 2000–2017
Characteristics | No. of patients(%) | Age-adjusted incidence rate(95% CI) |
---|---|---|
Overall | 24,417 (100) | 13.16 (12.99–13.32) |
Gender | ||
Male | 13,456 (55.1) | 16.85 (16.57–17.14) |
Female | 10,961 (44.9) | 10.39 (10.20–10.59) |
Race | ||
Non-Hispanic White | 20,406 (83.6) | 15.10 (14.89–15.31) |
Non-Hispanic Black | 1089 (4.5) | 6.92 (6.51–7.35) |
Hispanic | 1900 (7.8) | 10.58 (10.11–11.08) |
API | 927 (3.8) | 5.90 (5.52–6.29) |
AIAN | 61 (0.3) | 5.52 (4.20–7.14) |
Age at diagnosis, years | ||
65–69 | 6738 (27.6) | 11.67 (11.39–11.95) |
70–74 | 6287 (25.7) | 14.12 (13.77–14.47) |
75–79 | 5412 (22.2) | 15.47 (15.06–15.89) |
80–84 | 3700 (15.2) | 14.24 (13.78–14.70) |
≥85 | 2280 (9.3) | 9.19 (8.81–9.57) |
Histologic type | ||
Glioblastoma, NOS | 23,762 (97.3) | 12.80 (12.64–12.97) |
Giant cell glioblastoma | 172 (0.7) | 0.09 (0.08–0.11) |
Gliosarcoma | 483 (2.0) | 0.26 (0.24–0.28) |
Tumor location | ||
Supratentorial | 18,089 (74.1) | 9.74 (9.60–9.89) |
Frontal | 6220 (25.5) | 3.34 (3.26–3.43) |
Temporal | 6059 (24.8) | 3.27 (3.19–3.35) |
Parietal | 3911 (16.0) | 2.11 (2.04–2.17) |
Occipital | 1148 (4.7) | 0.62 (0.59–0.66) |
Infratentorial | 195 (0.8) | 0.11 (0.09–0.12) |
Overlapping/NOS | 6133 (25.1) | 3.31 (3.22–3.39) |
Tumor size, cma | ||
< 4 | 5082 (30.7) | 2.73 (2.65–2.81) |
≥4 | 8387 (50.7) | 4.51 (4.42–4.61) |
Unknown | 3058 (18.5) | 2.47 (2.38–2.56) |